SLDB
Solid Biosciences (SLDB) P/E Ratio
P/E Ratio as of Oct 26, 2026: -3.04
Average-3.39
Median-3.52
Minimum-3.81
Maximum-2.86
-3.04
0.78 (20.42%)past month
The P/E ratio for Solid Biosciences (SLDB) is -3.04 as of Oct 26, 2026. This represents a decrease of -10.06% compared to its 12-month average P/E ratio of -3.38. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Solid Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Solid Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Solid Biosciences to industry peers.
Solid Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Solid Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Solid Biosciences to industry peers.
Solid Biosciences (SLDB) P/E Ratio Insights
See Solid Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Solid Biosciences (SLDB)
Order type
Buy in
Order amount
Est. shares
0 shares
Solid Biosciences (SLDB) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $6.98 | -3.66 |
| Sep 1, 2026 | $9.88 | -5.18 |
| Aug 3, 2026 | $8.02 | -4.12 |
| Jul 1, 2026 | $10.20 | -5.24 |
| Jun 1, 2026 | $7.19 | -3.69 |
| May 1, 2026 | $7.13 | -3.53 |
| Apr 1, 2026 | $7.38 | -3.65 |
| Mar 2, 2026 | $6.20 | -2.49 |
| Feb 2, 2026 | $6.43 | -2.58 |
| Jan 2, 2026 | $5.45 | -2.19 |
Solid Biosciences (SLDB) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -3.04 | +34.51% |
| 2025 | -2.26 | +71.21% |
| 2024 | -1.32 | -0.75% |
| 2023 | -1.33 | +195.56% |
| 2022 | -0.45 | -82.42% |
| 2021 | -2.56 | — |
FAQs About Solid Biosciences (SLDB) P/E ratio
The latest P/E ratio of Solid Biosciences (SLDB) is -3.04, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Solid Biosciences’s last 12-month average P/E ratio is -3.38, compared to its current P/E ratio of -3.04. This reflects a decrease of -10.06%.
Solid Biosciences’s current P/E ratio of -3.04 is lower than its last 12-month average P/E of -3.38. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Solid Biosciences’s average P/E ratio over the last 3 years is -2.29. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Solid Biosciences’s average P/E ratio over the last 5 years is -1.77. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Solid Biosciences (SLDB) P/E Ratio Insights
See Solid Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Solid Biosciences (SLDB)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.